Establishing a service to tackle problematic polypharmacy
Author(s) -
Frances Bennett,
Neha Shah,
Robin E. Offord,
R E Ferner,
Reecha Sofat
Publication year - 2020
Publication title -
future healthcare journal
Language(s) - English
Resource type - Journals
eISSN - 2514-6653
pISSN - 2514-6645
DOI - 10.7861/fhj.2019-0048
Subject(s) - polypharmacy , medicine , deprescribing , interquartile range , drug reaction , adverse effect , primary care , secondary care , emergency medicine , intervention (counseling) , intensive care medicine , drug , family medicine , pharmacology , nursing
Polypharmacy is increasingly common and can increase the risk of adverse drug reactions (ADRs), accounting for a significant proportion of hospital admissions. It may also impair functional status and quality of life. Current efforts to improve polypharmacy take place largely in primary care, but there may be a role for increased support from medicines specialists in the secondary care setting.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom